Quarterly Result29 May 2026, 01:48 am
Gaudium IVF Board Approves Q4 & FY26 Audited Financial Results
AI Summary
Gaudium IVF and Women Health Limited's Board of Directors, at its meeting on May 28, 2026, approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The results include an unmodified auditor's report issued by S K G N & Associates LLP, in compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The trading window for designated persons and their immediate relatives remains closed until May 30, 2026.
Key Highlights
- Board approved Q4 and FY26 audited standalone and consolidated financial results.
- Auditor S K G N & Associates LLP issued an unmodified report on the results.
- The approval is in compliance with SEBI Listing Regulations.
- Trading window for designated persons closed until May 30, 2026.
Price Impact
More from GAUDIUMIVF